Home › Funds › Avanza Fonder AB › ABT

Avanza Fonder AB position in ABT

ABBOTT LABORATORIES · Health Care

Avanza Fonder AB reported holding 211,093 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$20.9M, representing 0.40% of its reported portfolio and ranking #41 among its reported holdings. Avanza Fonder AB has disclosed ABT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)211.09K sh
Reported value held$20.86M
Portfolio Weight0.40%
First reportedQ4 2024
Last changeAdd
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Avanza Fonder AB's ABT position evolved

Avanza Fonder AB first disclosed a stake in ABT in Q4 2024 at 182,445 shares (US$20.6M). The position peaked in Q4 2025 at 195,451 shares, worth US$24.5M. Across 8 filings, Avanza Fonder AB increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 211,093 shares valued at US$20.9M — an increase of 22,234 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2024 182.44K $20.64M New
Q1 2025 167.75K $22.13M Reduce
Q2 2025 168.40K $22.90M Hold
Q3 2025 179.29K $24.01M Add
Q4 2025 195.45K $24.49M Add
Q1 2026 194.85K $20.01M Hold
Q2 2026 188.86K $17.14M Reduce
Q3 2026 211.09K $20.86M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Avanza Fonder AB held ABT?

Avanza Fonder AB has disclosed ABT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Avanza Fonder AB's current position in ABT?

As of Q3 2026, Avanza Fonder AB holds 211.09K shares of ABT (ABBOTT LABORATORIES), valued at $20.86M, representing 0.40% of its reported portfolio and ranking #41.

Has Avanza Fonder AB been buying or selling ABT?

In the latest 13F filing (Q3 2026), Avanza Fonder AB increased its position in ABT. The position peaked in Q4 2025 at 195.45K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.